These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12836410)

  • 21. Genetic and clinical heterogeneity in eIF2B-related disorder.
    Maletkovic J; Schiffmann R; Gorospe JR; Gordon ES; Mintz M; Hoffman EP; Alper G; Lynch DR; Singhal BS; Harding C; Amartino H; Brown CM; Chan A; Renaud D; Geraghty M; Jensen L; Senbil N; Kadom N; Nazarian J; Yuanjian Feng ; Zuyi Wang ; Hartka T; Morizono H; Vanderver A
    J Child Neurol; 2008 Feb; 23(2):205-15. PubMed ID: 18263758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel mutations identified in EIF2B5 gene in Kashmiri patients as susceptibility factor for multiple sclerosis.
    Zahoor I; Hamid Z; Asimi R; Haq E
    Indian J Biochem Biophys; 2014 Apr; 51(2):115-20. PubMed ID: 24980014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The large spectrum of eIF2B-related diseases.
    Fogli A; Boespflug-Tanguy O
    Biochem Soc Trans; 2006 Feb; 34(Pt 1):22-9. PubMed ID: 16246171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lost in translation.
    Julier C
    Nat Genet; 2001 Dec; 29(4):358-9. PubMed ID: 11726916
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-eIF2B-related cystic leukoencephalopathy of unknown origin.
    van der Knaap MS; Scheper GC
    Ann Neurol; 2006 Apr; 59(4):724. PubMed ID: 16566013
    [No Abstract]   [Full Text] [Related]  

  • 26. Clues to the mechanism of action of eIF2B, the guanine-nucleotide-exchange factor for translation initiation.
    Mohammad-Qureshi SS; Jennings MD; Pavitt GD
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):658-64. PubMed ID: 18631136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No evidence for association between the EIF2B5 gene and multiple sclerosis in French families.
    Fogli A; Barbier C; Cournu-Rebeix I; Babron MC; Clerget-Darpoux F; Fontaine B; Boespflug-Tanguy O
    Mult Scler; 2008 May; 14(4):573. PubMed ID: 18562513
    [No Abstract]   [Full Text] [Related]  

  • 28. A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter.
    Geva M; Cabilly Y; Assaf Y; Mindroul N; Marom L; Raini G; Pinchasi D; Elroy-Stein O
    Brain; 2010 Aug; 133(Pt 8):2448-61. PubMed ID: 20826436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of translational control of eukaryotic gene expression using yeast.
    Hinnebusch AG; Asano K; Olsen DS; Phan L; Nielsen KH; Valásek L
    Ann N Y Acad Sci; 2004 Dec; 1038():60-74. PubMed ID: 15838098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dominant form of vanishing white matter-like leukoencephalopathy.
    Labauge P; Fogli A; Castelnovo G; Le Bayon A; Horzinski L; Nicoli F; Cozzone P; Pagès M; Briere C; Marty-Double C; Delhaume O; Gelot A; Boespflug-Tanguy O; Rodriguez D
    Ann Neurol; 2005 Oct; 58(4):634-9. PubMed ID: 16047349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caerulein-induced acute pancreatitis inhibits protein synthesis through effects on eIF2B and eIF4F.
    Sans MD; DiMagno MJ; D'Alecy LG; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G517-28. PubMed ID: 12773302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease.
    Damon-Perriere N; Menegon P; Olivier A; Boespflug-Tanguy O; Niel F; Creveaux I; Dousset V; Brochet B; Goizet C
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1068-71. PubMed ID: 18845387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of CCK and intracellular calcium to regulate eIF2B and protein synthesis in rat pancreatic acinar cells.
    Sans MD; Kimball SR; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2002 Feb; 282(2):G267-76. PubMed ID: 11804848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular medicine: lost in translation.
    Ainsworth C
    Nature; 2005 Jun; 435(7042):556-8. PubMed ID: 15931189
    [No Abstract]   [Full Text] [Related]  

  • 35. An emergency brake for protein synthesis.
    Hronová V; Valášek LS
    Elife; 2017 Apr; 6():. PubMed ID: 28440747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Advances in functional study of EIF2B mutations in leukoencephalopathy with vanishing white matter].
    Leng XR; Wu Y; Jiang YW
    Sheng Li Ke Xue Jin Zhan; 2010 Apr; 41(2):125-8. PubMed ID: 21416999
    [No Abstract]   [Full Text] [Related]  

  • 37. Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation.
    Federico A; Scali O; Stromillo ML; Di Perri C; Bianchi S; Sicurelli F; De Stefano N; Malandrini A; Dotti MT
    Neurology; 2006 Jul; 67(2):353-5. PubMed ID: 16864840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eukaryotic initiation factor 2B: identification of multiple phosphorylation sites in the epsilon-subunit and their functions in vivo.
    Wang X; Paulin FE; Campbell LE; Gomez E; O'Brien K; Morrice N; Proud CG
    EMBO J; 2001 Aug; 20(16):4349-59. PubMed ID: 11500362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of ten novel mutations in patients with eIF2B-related disorders.
    Ohlenbusch A; Henneke M; Brockmann K; Goerg M; Hanefeld F; Kohlschütter A; Gärtner J
    Hum Mutat; 2005 Apr; 25(4):411. PubMed ID: 15776425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired protein synthesis induced by acute alcohol intoxication is associated with changes in eIF4E in muscle and eIF2B in liver.
    Lang CH; Frost RA; Kumar V; Wu D; Vary TC
    Alcohol Clin Exp Res; 2000 Mar; 24(3):322-31. PubMed ID: 10776669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.